Elise Regina, OD
Optometrist · New York, NYNPI 1588398978
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 182 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,520, 4.0 times the $378 reported in 2022. Among optometrist clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 182 payments — averaging $22.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Oyster Point Pharma, Inc.$859
- Harrow Eye, LLC$769
- Bausch & Lomb Americas Inc.$593
- Sun Pharmaceutical Industries Inc.$531
- AbbVie$396
- Alcon$395
- plus $619 from 9 others
What the payments were for
- Food & beverage$4,163100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Oyster Point Pharma, Inc. | 34 | $859 |
| Harrow Eye, LLC | 43 | $769 |
| Bausch & Lomb Americas Inc. | 20 | $593 |
| Sun Pharmaceutical Industries Inc. | 30 | $531 |
| AbbVie | 22 | $396 |
| Alcon | 15 | $395 |
| Sight Sciences, Inc. | 2 | $168 |
| Tarsus Pharmaceuticals, Inc. | 6 | $160 |
| Glaukos Corporation | 1 | $72 |
| Mallinckrodt Hospital Products Inc. | 2 | $65 |
| Coopervision Inc. | 2 | $45 |
| Thea Pharma Inc. | 2 | $39 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $24 |
| Dompe US, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,163 in reported general payments places this provider in the 90th percentile of 2,743 optometrist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 16 | $1,132 |
| Ketorolac Tromethamine | 23 | $442 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 18 | $289 |
| Latanoprost | 30 | $186 |
| ErythromycinErythromycin Base | 17 | $178 |
Paid to pharmacies, not to this prescriber.
Other optometrist in New York
- Susan ResnickNew York$463K
- Denise WhittamNew York$343K
- Jennifer TsaiNew York$275K
- Sophia VisanjiNew York$233K
- Jason ComptonNew York$181K
- Richard MadonnaNew York$75K
- George ZikosNew York$72K
- Craig TischNew York$59K
- Arthur JungNew York$50K
- Milly MuiNew York$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.